Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag v3.5.3 was added and the previous tag v3.5.2 was removed, indicating an update to the page's revision metadata rather than changes to the visible study content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedSite revision updated to v3.5.0; the previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.4.2 replaces the previous Revision: v3.4.1.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous v3.4.0; this is a minor version update and does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.